Seed VC · Italy

Angelini Ventures

Active

What they invest in

We invest in BioTech and HealthTech companies that transform healthcare. Our focus is on leveraging technology to improve healthcare, reshape patient journeys, and address unmet needs in vulnerable populations.

Who they back

DeepTechHealthtechBiotechHealthcaredigital health and biotechPre-seedSeedSeries A

Business models

deeptech_ip, biotech_therapeutics

Customer segments

Enterprise, Healthcare providers, Patients

Geography

US, Europe, APAC

Recent investments

  • Hypervision Surgical
  • Enodia Therapeutics

The people who write checks

7 partners on file at Angelini Ventures, with the firm's email pattern for cold outreach. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 47,000+ others.

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Angelini Ventures writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Angelini Ventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
Italy
Last known deal
Dec 2022
Website
www.angeliniventures.com ↗

Other firms investing in DeepTech

See all investors

Is Angelini Ventures the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Angelini Ventures is one of them, and we'll tell you exactly where they sit in your top 100.